Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample ; volume:15 ; number:1 ; day:3 ; month:3 ; year:2023 ; pages:1-10 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (3.3.2023), 1-10, 12.2023
- Urheber
-
Arvidsson Rådestig, Maya
Skoog, Ingmar
Skillbäck, Tobias
Zetterberg, Henrik
Kern, Jürgen
Zettergren, Anna
Andreasson, Ulf
Wetterberg, Hanna
Kern, Silke
Blennow, Kaj
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01193-x
- URN
-
urn:nbn:de:101:1-2024022014422060247698
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arvidsson Rådestig, Maya
- Skoog, Ingmar
- Skillbäck, Tobias
- Zetterberg, Henrik
- Kern, Jürgen
- Zettergren, Anna
- Andreasson, Ulf
- Wetterberg, Hanna
- Kern, Silke
- Blennow, Kaj
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury